BioSpace News Archive

CSL Behring Presents Results for Garadacimab as Preventive Treatment in Hereditary Angioedema

CSL Behring, a global biotherapeutics leader, announced results of a Phase 2 clinical trial for garadacimab, an investigational novel Factor XIIa-inhibitory monoclonal antibody in development as a preventive treatment in hereditary angioedema.

June 8, 2020
·
7 min read
Ipsen Demonstrates Continued Commitment to Rare Diseases With Eight Abstracts Accepted at ENDO 2020 Published in the Journal of the Endocrine Society

Data published evaluates fibrodysplasia ossificans progressiva (FOP) natural disease progression

June 8, 2020
·
15 min read
Pharm Country

Relief Therapeutics and NeuroRx Expand Clinical Trial of RLF-100 to All Patients with Critical COVID-19 and Respiratory Failure

RELIEF THERAPEUTICS Holding AG “Relief” and its U.S. partner, NeuroRx, Inc. announced that the Phase 2/3 clinical trial evaluating RLF-100 as a treatment for critical COVID-19 with respiratory failure has been expanded to include patients receiving high flow oxygen and noninvasive ventilation, in addition to those on ventilators.

June 8, 2020
·
7 min read